Drs. Robert Warren and Carlos Corvera Awarded Pilot Grant by Collaborative Dedicated to Reducing Health Disparities in Cancer
Robert S. Warren, M.D. and Carlos U. Corvera, M.D. are co-Principal Investigators on a pilot grant funded through the University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities collaborative.
Comprised of four of the University of California’s NCI-designated comprehensive cancer centers: UC Davis Comprehensive Cancer Center, Jonsson Comprehensive Cancer Center at UCLA, UCSF Helen Diller Family Comprehensive Cancer Center and the Chao Family Comprehensive Cancer Center at UC Irvine, the collaborative is funded by a $6M grant from the National Cancer Institute’s Center to Reduce Cancer Health Disparities.
The four centers are part of the recently created UC Cancer Center Consortium, and their patient population is among the most diverse in the U.S.
The pilot study by Dr. Warren and Dr. Corvera is entitled: “Establishment of Intrahepatic Cholangiocarcinoma Patient-Derived Xenografts from Hispanic/Latino Patients."
Related Links
Study seeks to improve cancer survival for Latinos, Asians and Blacks